| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |